These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 39011654)

  • 21. Proteomic Profile of Procoagulant Extracellular Vesicles Reflects Complement System Activation and Platelet Hyperreactivity of Patients with Severe COVID-19.
    Moraes ECDS; Martins-Gonçalves R; da Silva LR; Mandacaru SC; Melo RM; Azevedo-Quintanilha I; Perales J; Bozza FA; Souza TML; Castro-Faria-Neto HC; Hottz ED; Bozza PT; Trugilho MRO
    Front Cell Infect Microbiol; 2022; 12():926352. PubMed ID: 35937696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative Proteomics Analysis of Tissue Interstitial Fluid for Identification of Novel Serum Candidate Diagnostic Marker for Hepatocellular Carcinoma.
    Sun W; Xing B; Guo L; Liu Z; Mu J; Sun L; Wei H; Zhao X; Qian X; Jiang Y; He F
    Sci Rep; 2016 May; 6():26499. PubMed ID: 27216119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteomic profiling of aspergillus flavus endophthalmitis derived extracellular vesicles in an in-vivo murine model.
    Gandhi J; Naik MN; Mishra DK; Joseph J
    Med Mycol; 2022 Sep; 60(9):. PubMed ID: 36002004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of von Willebrand factor as a biomarker of tumor development in hepatitis B virus-associated human hepatocellular carcinoma: a quantitative proteomic based study.
    Liu Y; Wang X; Li S; Hu H; Zhang D; Hu P; Yang Y; Ren H
    J Proteomics; 2014 Jun; 106():99-112. PubMed ID: 24769235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Combination of Proteomic Approaches Identifies A Panel of Circulating Extracellular Vesicle Proteins Related to the Risk of Suffering Cardiovascular Disease in Obese Patients.
    Barrachina MN; Sueiro AM; Casas V; Izquierdo I; Hermida-Nogueira L; Guitián E; Casanueva FF; Abián J; Carrascal M; Pardo M; García Á
    Proteomics; 2019 Jan; 19(1-2):e1800248. PubMed ID: 30536591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of potential saliva and tear biomarkers in primary Sjögren's syndrome, utilising the extraction of extracellular vesicles and proteomics analysis.
    Aqrawi LA; Galtung HK; Vestad B; Øvstebø R; Thiede B; Rusthen S; Young A; Guerreiro EM; Utheim TP; Chen X; Utheim ØA; Palm Ø; Jensen JL
    Arthritis Res Ther; 2017 Jan; 19(1):14. PubMed ID: 28122643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteome Differences between Hepatitis B Virus Genotype-B- and Genotype-C-Induced Hepatocellular Carcinoma Revealed by iTRAQ-Based Quantitative Proteomics.
    Wei D; Zeng Y; Xing X; Liu H; Lin M; Han X; Liu X; Liu J
    J Proteome Res; 2016 Feb; 15(2):487-98. PubMed ID: 26709725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative proteome analysis of plasma microparticles for the characterization of HCV-induced hepatic cirrhosis and hepatocellular carcinoma.
    Taleb RSZ; Moez P; Younan D; Eisenacher M; Tenbusch M; Sitek B; Bracht T
    Proteomics Clin Appl; 2017 Dec; 11(11-12):. PubMed ID: 28626882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolomic Characterization of Hepatocellular Carcinoma in Patients with Liver Cirrhosis for Biomarker Discovery.
    Di Poto C; Ferrarini A; Zhao Y; Varghese RS; Tu C; Zuo Y; Wang M; Nezami Ranjbar MR; Luo Y; Zhang C; Desai CS; Shetty K; Tadesse MG; Ressom HW
    Cancer Epidemiol Biomarkers Prev; 2017 May; 26(5):675-683. PubMed ID: 27913395
    [No Abstract]   [Full Text] [Related]  

  • 30. Proteomic analysis of HCV cirrhosis and HCV-induced HCC: identifying biomarkers for monitoring HCV-cirrhotic patients awaiting liver transplantation.
    Mas VR; Maluf DG; Archer KJ; Yanek K; Bornstein K; Fisher RA
    Transplantation; 2009 Jan; 87(1):143-52. PubMed ID: 19136905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of human hepatocellular carcinoma-related proteins by proteomic approaches.
    Yang MH; Tyan YC; Jong SB; Huang YF; Liao PC; Wang MC
    Anal Bioanal Chem; 2007 Jun; 388(3):637-43. PubMed ID: 17447055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum extracellular vesicles contain SPARC and LRG1 as biomarkers of colon cancer and differ by tumour primary location.
    Zhong ME; Chen Y; Xiao Y; Xu L; Zhang G; Lu J; Qiu H; Ge W; Wu B
    EBioMedicine; 2019 Dec; 50():211-223. PubMed ID: 31753726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of biomarkers for screening hepatocellular carcinoma using global data mining and multiple reaction monitoring.
    Kim H; Kim K; Yu SJ; Jang ES; Yu J; Cho G; Yoon JH; Kim Y
    PLoS One; 2013; 8(5):e63468. PubMed ID: 23717429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RASSF1A and SOCS1 genes methylation status as a noninvasive marker for hepatocellular carcinoma.
    Pasha HF; Mohamed RH; Radwan MI
    Cancer Biomark; 2019; 24(2):241-247. PubMed ID: 30689554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ovarian cancer circulating extracelluar vesicles promote coagulation and have a potential in diagnosis: an iTRAQ based proteomic analysis.
    Zhang W; Peng P; Ou X; Shen K; Wu X
    BMC Cancer; 2019 Nov; 19(1):1095. PubMed ID: 31718609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utilization of metabolomics to identify serum biomarkers for hepatocellular carcinoma in patients with liver cirrhosis.
    Ressom HW; Xiao JF; Tuli L; Varghese RS; Zhou B; Tsai TH; Ranjbar MR; Zhao Y; Wang J; Di Poto C; Cheema AK; Tadesse MG; Goldman R; Shetty K
    Anal Chim Acta; 2012 Sep; 743():90-100. PubMed ID: 22882828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insights into immune responses in oral cancer through proteomic analysis of saliva and salivary extracellular vesicles.
    Winck FV; Prado Ribeiro AC; Ramos Domingues R; Ling LY; Riaño-Pachón DM; Rivera C; Brandão TB; Gouvea AF; Santos-Silva AR; Coletta RD; Paes Leme AF
    Sci Rep; 2015 Nov; 5():16305. PubMed ID: 26538482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycosylation change of alpha-1-acid glycoprotein as a serum biomarker for hepatocellular carcinoma and cirrhosis.
    Zhang D; Huang J; Luo D; Feng X; Liu Y; Liu Y
    Biomark Med; 2017 May; 11(5):423-430. PubMed ID: 28621608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
    Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
    J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of N-glycosylation in hepatocellular carcinoma patients' serum with a comparative proteomic approach.
    Huang Y; Wu H; Xue R; Liu T; Dong L; Yao J; Zhang Y; Shen X
    PLoS One; 2013; 8(10):e77161. PubMed ID: 24143209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.